Compare this test’s laboratory options
ANA Multiplex, with Reflex to dsDNA
Quest Diagnostics1 test optionFrom $248.93
ANA Multiplex, with Reflex to dsDNA
Quest DiagnosticsCatalog information reviewed: August 24, 2026 by the Sunridge Medical clinical team.
What this laboratory test evaluates
DetailsANA Multiplex, with Reflex to dsDNA – This multiplex immunoassay detects common antinuclear antibodies (ANAs) that are associated with autoimmune diseases. With a reflex to double-stranded DNA (dsDNA), this test may aid in the evaluation of systemic lupus erythematosus (SLE). Because of its limited sensitivity compared to that of ANA immunofluorescence-based tests, multiplex immunoassay is not the preferred assay for ANA testing [1].
This multiplex immunoassay identifies antibodies to dsDNA, chromatin, ribosomal protein, SSA, SSB, Sm, Sm/RNP, RNP, Scl-70, Jo-1, and centromere B. A positive result indicates the presence of at least one of these autoantibodies. These autoantibodies have been associated with several autoimmune diseases, including SLE, systemic sclerosis, mixed connective tissue disease, polymyositis, and Sjogren syndrome. Antibodies to dsDNA are highly specific for SLE and may be detected before flares of the disease [2]. The 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria include antibodies to dsDNA in their immunology domains and criteria for SLE [3].
A negative result of this test indicates none of the component autoantibodies were detected but does not rule out the autoimmune diseases characterized by other autoantibodies, such as autoimmune hepatitis and primary biliary cholangitis. The classic ANA immunofluorescence assay on human epithelial type 2 cells, an assay that can detect up to 150 antibodies, is considered by the ACR as the current gold standard for ANA testing [1].
The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.
References
1. Methodology of testing for antinuclear antibodies (position statement). 2009. American College of Rheumatology. Updated December 2019. Accessed May 15, 2023.
2. Tozzoli R, et al. Am J Clin Pathol. 2002;117(2):316-324.
3. Aringer M, et al. Ann Rheum Dis. 2019;78(9):1151-1159.
What type of sample is required for this test?1 mL serum
Test ResourcesFor more information, please consult your healthcare provider.
Additional test information
ANA Multiplex, with Reflex to dsDNA – This multiplex immunoassay detects common antinuclear antibodies (ANAs) that are associated with autoimmune diseases. With a reflex to double-stranded DNA (dsDNA), this test may aid in the evaluation of systemic lupus erythematosus (SLE).
Collection and processing
- Sample type: Serum
- Fasting: No
- Estimated laboratory processing: Results should be available in 2 – 5 business days after the sample is collected
How Sunridge uses laboratory information
Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.
Before requesting this test
Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.
Common questions about this laboratory test
- What sample does this test require?
- The listed sample type is Serum. Confirm current collection instructions in the approved order.
- Does this test require fasting?
- The current catalog record lists fasting as: No. Follow the instructions supplied with the approved order.
- How long does laboratory processing usually take?
- Results should be available in 2 – 5 business days after the sample is collected. Timing can change after collection or if a laboratory requires additional review.
About this test
DetailsANA Multiplex, with Reflex to dsDNA - This multiplex immunoassay detects common antinuclear antibodies (ANAs) that are associated with autoimmune diseases. With a reflex to double-stranded DNA (dsDNA), this test may aid in the evaluation of systemic lupus erythematosus (SLE). Because of its limited sensitivity compared to that of ANA immunofluorescence-based tests, multiplex immunoassay is not the preferred assay for ANA testing [1].
This multiplex immunoassay identifies antibodies to dsDNA, chromatin, ribosomal protein, SSA, SSB, Sm, Sm/RNP, RNP, Scl-70, Jo-1, and centromere B. A positive result indicates the presence of at least one of these autoantibodies. These autoantibodies have been associated with several autoimmune diseases, including SLE, systemic sclerosis, mixed connective tissue disease, polymyositis, and Sjogren syndrome. Antibodies to dsDNA are highly specific for SLE and may be detected before flares of the disease [2]. The 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria include antibodies to dsDNA in their immunology domains and criteria for SLE [3].
A negative result of this test indicates none of the component autoantibodies were detected but does not rule out the autoimmune diseases characterized by other autoantibodies, such as autoimmune hepatitis and primary biliary cholangitis. The classic ANA immunofluorescence assay on human epithelial type 2 cells, an assay that can detect up to 150 antibodies, is considered by the ACR as the current gold standard for ANA testing [1].
The results of this test should be interpreted in the context of pertinent clinical and family history and physical examination findings.
References
1. Methodology of testing for antinuclear antibodies (position statement). 2009. American College of Rheumatology. Updated December 2019. Accessed May 15, 2023.
2. Tozzoli R, et al. Am J Clin Pathol. 2002;117(2):316-324.
3. Aringer M, et al. Ann Rheum Dis. 2019;78(9):1151-1159.
What type of sample is required for this test?1 mL serum
Test ResourcesFor more information, please consult your healthcare provider.
Additional details
ANA Multiplex, with Reflex to dsDNA - This multiplex immunoassay detects common antinuclear antibodies (ANAs) that are associated with autoimmune diseases. With a reflex to double-stranded DNA (dsDNA), this test may aid in the evaluation of systemic lupus erythematosus (SLE).
Highlighted health areas
- Autoimmune
Biomarkers and report focus
The exact analytes and report format can change. Confirm the current contents in the Fullscript order before payment.
- Antinuclear Antibodies Screen (Immunoassay)
- DNA (ds) Antibody